179 related articles for article (PubMed ID: 36063878)
21. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of cilnidipine loaded PLGA nanoparticles: process optimization by DoE, physico-chemical characterization and in vivo evaluation.
Diwan R; Khan S; Ravi PR
Drug Deliv Transl Res; 2020 Oct; 10(5):1442-1458. PubMed ID: 32329025
[TBL] [Abstract][Full Text] [Related]
23.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
24. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
25. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
Javia A; Thakkar H
J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
[TBL] [Abstract][Full Text] [Related]
26. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
[TBL] [Abstract][Full Text] [Related]
27. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
28. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
29. Preparation and Optimization of Leuprolide Acetate Nanoparticles Using Response Surface Methodology:
Pandya T; Dharamsi A
Assay Drug Dev Technol; 2022 Jul; 20(5):237-249. PubMed ID: 35852824
[TBL] [Abstract][Full Text] [Related]
30. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.
Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J
Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593
[TBL] [Abstract][Full Text] [Related]
31. Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,
Ameeduzzafar ; Khan N; Alruwaili NK; Bukhari SNA; Alsuwayt B; Afzal M; Akhter S; Yasir M; Elmowafy M; Shalaby K; Ali A
Iran J Pharm Res; 2020; 19(1):292-311. PubMed ID: 32922488
[TBL] [Abstract][Full Text] [Related]
32. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
33. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
Patil GB; Surana SJ
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
[TBL] [Abstract][Full Text] [Related]
34. Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
Jeong SH; Jang JH; Lee YB
J Control Release; 2021 Jul; 335():86-102. PubMed ID: 34015399
[TBL] [Abstract][Full Text] [Related]
35. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
Lee SY; Koo JS; Yang M; Cho HJ
J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352
[TBL] [Abstract][Full Text] [Related]
36. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation.
Sharma D; Maheshwari D; Philip G; Rana R; Bhatia S; Singh M; Gabrani R; Sharma SK; Ali J; Sharma RK; Dang S
Biomed Res Int; 2014; 2014():156010. PubMed ID: 25126544
[TBL] [Abstract][Full Text] [Related]
37. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
38. Repaglinide-Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box-Behnken Design, Characterization, and In Vivo Evaluation.
Ali HSM; Namazi N; Elbadawy HM; El-Sayed AAA; Ahmed SA; Bafail R; Almikhlafi MA; Alahmadi YM
Int J Nanomedicine; 2024; 19():209-230. PubMed ID: 38223883
[TBL] [Abstract][Full Text] [Related]
39. Formulation and evaluation of butenafine loaded PLGA-nanoparticulate laden chitosan nano gel.
Alshehri S; Imam SS
Drug Deliv; 2021 Dec; 28(1):2348-2360. PubMed ID: 34747275
[TBL] [Abstract][Full Text] [Related]
40. Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.
Ahmad S; Khan I; Pandit J; Emad NA; Bano S; Dar KI; Rizvi MMA; Ansari MD; Aqil M; Sultana Y
Int J Biol Macromol; 2022 Nov; 221():435-445. PubMed ID: 36067850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
